메뉴 건너뛰기




Volumn 17, Issue 11, 2010, Pages 1810-1816

Responses to a conjugate pneumococcal vaccine in preterm infants immunized at 2, 3, and 4 months of age

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B POLIOMYELITIS VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY; MENINGOCOCCUS VACCINE; ORAL POLIOMYELITIS VACCINE; PEDIACEL; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

EID: 78449231479     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00214-10     Document Type: Article
Times cited : (20)

References (15)
  • 1
    • 33646350017 scopus 로고    scopus 로고
    • Haemophilus influenzae type b immunization in infants in the United Kingdom: Effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose
    • Berrington, J. E., A. J. Cant, J. N. Matthews, M. O'Keeffe, G. P. Spickett, and A. C. Fenton. 2006. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose. Pediatrics 117:e717-e724.
    • (2006) Pediatrics , vol.117
    • Berrington, J.E.1    Cant, A.J.2    Matthews, J.N.3    O'Keeffe, M.4    Spickett, G.P.5    Fenton, A.C.6
  • 2
    • 30344447981 scopus 로고    scopus 로고
    • Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants
    • Broughton, S., R. Bhat, A. Roberts, M. Zuckerman, G. Rafferty, and A. Greenough. 2006. Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants. Arch. Dis. Child. 91:26-30.
    • (2006) Arch. Dis. Child. , vol.91 , pp. 26-30
    • Broughton, S.1    Bhat, R.2    Roberts, A.3    Zuckerman, M.4    Rafferty, G.5    Greenough, A.6
  • 5
    • 0004059713 scopus 로고    scopus 로고
    • Department of Health Immunisation against Infectious Diseases Department of Health Immunisation against Infectious Diseases, London, United Kingdom
    • Department of Health Immunisation against Infectious Diseases. 1996. The green book. Department of Health Immunisation against Infectious Diseases, London, United Kingdom.
    • (1996) The Green Book
  • 6
    • 13444249859 scopus 로고    scopus 로고
    • Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants
    • Esposito, S., L. Pugni, S. Bosis, A. Proto, L. Cesati, C. Bianchi, C. Cimino, F. Mosca, and N. Principi. 2005. Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants. Vaccine 23:1703-1708.
    • (2005) Vaccine , vol.23 , pp. 1703-1708
    • Esposito, S.1    Pugni, L.2    Bosis, S.3    Proto, A.4    Cesati, L.5    Bianchi, C.6    Cimino, C.7    Mosca, F.8    Principi, N.9
  • 8
    • 0035468744 scopus 로고    scopus 로고
    • Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance
    • Klugman, K. P. 2001. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect. Dis. 1:85-91.
    • (2001) Lancet Infect. Dis. , vol.1 , pp. 85-91
    • Klugman, K.P.1
  • 9
    • 0029979631 scopus 로고    scopus 로고
    • Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children
    • Langkamp, D. L., and J. P. Davis. 1996. Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children. J. Pediatr. 128:654-659.
    • (1996) J. Pediatr. , vol.128 , pp. 654-659
    • Langkamp, D.L.1    Davis, J.P.2
  • 11
    • 14744304513 scopus 로고    scopus 로고
    • Use of conjugate pneumococcal vaccine by United Kingdom neonatal intensive care units
    • Moss, S. J., A. C. Fenton, and A. R. Gennery. 2005. Use of conjugate pneumococcal vaccine by United Kingdom neonatal intensive care units. Arch. Dis. Child. Fetal Neonatal Ed. 90:F187-F188.
    • (2005) Arch. Dis. Child. Fetal Neonatal Ed. , vol.90
    • Moss, S.J.1    Fenton, A.C.2    Gennery, A.R.3
  • 12
    • 77649260036 scopus 로고    scopus 로고
    • Immunogenicity of a heptavalent conjugate pneumococcal vaccine administered concurrently with a combination diphtheria, tetanus, five-component acellular pertussis, inactivated polio, and Haemophilus influenzae type b vaccine and a meningococcal group C conjugate vaccine at 2, 3, and 4 months of age
    • Moss, S. J., A. C. Fenton, J. Toomey, A. Grainger, R. Borrow, P. Balmer, J. Smith, and A. R. Gennery. 2010. Immunogenicity of a heptavalent conjugate pneumococcal vaccine administered concurrently with a combination diphtheria, tetanus, five-component acellular pertussis, inactivated polio, and Haemophilus influenzae type b vaccine and a meningococcal group C conjugate vaccine at 2, 3, and 4 months of age. Clin. Vaccine Immunol. 17:311-316.
    • (2010) Clin. Vaccine Immunol. , vol.17 , pp. 311-316
    • Moss, S.J.1    Fenton, A.C.2    Toomey, J.3    Grainger, A.4    Borrow, R.5    Balmer, P.6    Smith, J.7    Gennery, A.R.8
  • 14
    • 0036188626 scopus 로고    scopus 로고
    • Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants
    • Shinefield, H., S. Black, P. Ray, B. Fireman, J. Schwalbe, and E. Lewis. 2002. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr. Infect. Dis. J. 21:182-186.
    • (2002) Pediatr. Infect. Dis. J. , vol.21 , pp. 182-186
    • Shinefield, H.1    Black, S.2    Ray, P.3    Fireman, B.4    Schwalbe, J.5    Lewis, E.6
  • 15
    • 33749856304 scopus 로고    scopus 로고
    • Recommendations for the production and control of pneumococcal conjugate vaccines
    • WHO. World Health Organization, Geneva, Switzerland
    • WHO. 2005. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO technical report series no. 927. World Health Organization, Geneva, Switzerland.
    • (2005) WHO Technical Report Series No. 927


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.